Income Statement Morgan Stanley

Equities

MS

US6174464486

Investment Banking & Brokerage Services

Real-time Estimate Cboe BZX Other stock markets 17:30:26 19/09/2024 BST			5-day change	1st Jan Change
100.86 ^USD	+1.57%		+4.28%	+8.08%

03:53pm	Myriad Genetics Has Many Opportunities for Growth, Needs Sustained Execution, Morgan Stanley Says	MT
03:48pm	Elanco Animal Health Downgraded by Morgan Stanley, Price Target Cut	MT

6b03d56749ca4fa243.McXu_Th40qPXKJShgo7IuHojh29X9TWVsNC0_dlZvw8.drXfunATt_O-fdXw27iy9BdmwTc6mFLHheDArrUp3GVe8deETyeR4q5b2Q

Published financial data: MORGAN STANLEY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Interest and Dividend Income, Total	18.64B	11.15B	10.79B	21.61B	50.85B
Interest Expense, Total	12.4B	3.85B	1.37B	12.27B	42.05B
Net Interest Income	6.23B	7.3B	9.42B	9.34B	8.8B
Brokerage Commission	3.92B	4.85B	5.52B	4.94B	4.54B
Trading and Principal Transactions	11.1B	13.99B	12.81B	13.93B	15.26B
Asset Management Fee	13.08B	14.27B	19.97B	19.58B	19.62B
Underwriting & Investment Banking Fee	6.16B	7.67B	10.99B	5.6B	4.95B
Gain (Loss) on Sale of Investments, Total (Rev)	47M	81M	210M	70M	49M
Other Revenues, Total	878M	29M	832M	213M	926M
Revenues Before Provison For Loan Losses	41.42B	48.2B	59.76B	53.67B	54.14B
Provision For Loan Losses	-	-	4M	280M	532M
Total Revenues	41.42B	48.2B	59.75B	53.39B	53.61B
Salaries And Other Employee Benefits	18.66B	20.7B	24.53B	23.01B	24.2B
Cost of Services Provided, Total	8.91B	9.59B	11.76B	12.66B	13.1B
Other Operating Expenses	-	-	-	-	-
Total Operating Expenses	27.58B	30.3B	36.29B	35.67B	37.31B
Operating Income	13.84B	17.9B	23.46B	17.72B	16.3B
Other Non Operating Income (Expenses)	-2.13B	-2.93B	-3.49B	-3.13B	-3.85B
EBT, Excl. Unusual Items	11.72B	14.98B	19.98B	14.59B	12.46B
Total Merger & Related Restructuring Charges	-	-151M	-102M	-41M	-
Impairment of Goodwill	-	-	-8M	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Asset Writedown	-22M	-70M	-42M	-17M	-43M
Legal Settlements	-221M	-336M	-157M	-443M	-249M
Other Unusual Items	-172M	-	-	-	-353M
EBT, Incl. Unusual Items	11.3B	14.42B	19.67B	14.09B	11.81B
Income Tax Expense	2.06B	3.24B	4.55B	2.91B	2.58B
Earnings From Continuing Operations	9.24B	11.18B	15.12B	11.18B	9.23B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	9.24B	11.18B	15.12B	11.18B	9.23B
Minority Interest	-195M	-183M	-86M	-150M	-143M
Net Income - (IS)	9.04B	11B	15.03B	11.03B	9.09B
Preferred Dividend and Other Adjustments	530M	496M	468M	489M	557M
Net Income to Common Incl Extra Items	8.51B	10.5B	14.57B	10.54B	8.53B
Net Income to Common Excl. Extra Items	8.51B	10.5B	14.57B	10.54B	8.53B
Per Share Items
Net EPS - Basic	5.26	6.55	8.16	6.23	5.24
Basic EPS - Continuing Operations	5.26	6.55	8.16	6.23	5.24
Basic Weighted Average Shares Outstanding	1.62B	1.6B	1.78B	1.69B	1.63B
Net EPS - Diluted	5.19	6.46	8.03	6.15	5.18
Diluted EPS - Continuing Operations	5.19	6.46	8.03	6.15	5.18
Diluted Weighted Average Shares Outstanding	1.64B	1.62B	1.81B	1.71B	1.65B
Normalized Basic EPS	4.41	5.72	6.95	5.3	4.69
Normalized Diluted EPS	4.35	5.65	6.84	5.24	4.64
Dividend Per Share	1.35	1.4	2.45	3.02	3.32
Payout Ratio	29.05	24.91	27.74	48.97	63.42
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
Effective Tax Rate - (Ratio)	18.26	22.46	23.12	20.65	21.87
Current Domestic Taxes	1.13B	2.04B	3.03B	2.96B	1.73B
Current Foreign Taxes	766M	1.45B	1.52B	799M	1.31B
Total Current Taxes	1.9B	3.49B	4.54B	3.76B	3.05B
Deferred Domestic Taxes	231M	-287M	22M	-945M	-354M
Deferred Foreign Taxes	-66M	37M	-18M	96M	-109M
Total Deferred Taxes	165M	-250M	4M	-849M	-463M
Normalized Net Income	7.13B	9.18B	12.4B	8.97B	7.64B
Non-Cash Pension Expense	39M	71M	91M	81M	35M
Supplemental Operating Expense Items
Stock-Based Comp., G&A Exp. (Total)	-	-	2.08B	1.88B	1.71B
Stock-Based Comp., Other (Total)	1.15B	1.31B	-	-	-
Total Stock-Based Compensation	1.15B	1.31B	2.08B	1.88B	1.71B

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	4.29B	106B	128B	128B	89.23B
Cash & Securities Segregated	-	-	-	-	-
Securities Purchased Under Agreements To Resell	88.22B	116B	120B	114B	111B
Securities Borrowed	107B	112B	130B	133B	121B
Accounts Receivable, Total	52.36B	94.23B	161B	108B	70.61B
Other Receivables	121B	141B	107B	167B	212B
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	4B	4.42B	4.27B	4.07B	4.37B
Goodwill	7.14B	11.64B	16.83B	16.65B	16.71B
Other Intangibles, Total	2.11B	4.98B	8.36B	7.62B	7.06B
Investment In Debt and Equity Securities	106B	182B	183B	160B	155B
Trading Asset Securities, Total	169B	181B	193B	179B	205B
Loans Held For Sale	12.58B	12.81B	13.83B	14.79B	15.26B
Restricted Cash	32.51B	-	-	-	-
Other Current Assets, Total	174B	133B	104B	124B	163B
Other Long-Term Assets, Total	16.12B	17.32B	19.22B	22.91B	23.87B
Total Assets	895B	1,116B	1,188B	1,180B	1,194B
Liabilities
Accounts Payable, Total	198B	227B	229B	216B	208B
Short-Term Borrowings	101B	117B	119B	121B	125B
Current Portion of Long-Term Debt	22.27B	26.2B	17.33B	25.1B	31.42B
Current Portion of Leases	763M	841M	886M	870M	913M
Long-Term Debt	175B	193B	216B	216B	242B
Long-Term Leases	4.02B	4.49B	4.27B	4.03B	4.5B
Trust Preferred Securities (BS)	-	-	-	-	-
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	125B	131B	130B	139B	141B
Other Non Current Liabilities	186B	313B	365B	356B	341B
Total Liabilities	813B	1,013B	1,082B	1,079B	1,094B
Preferred Stock Redeemable	8.52B	9.25B	7.75B	8.75B	8.75B
Total Preferred Equity	8.52B	9.25B	7.75B	8.75B	8.75B
Common Stock, Total	20M	20M	20M	20M	20M
Additional Paid In Capital	23.94B	25.55B	28.84B	29.34B	29.83B
Retained Earnings	70.59B	78.69B	89.43B	94.86B	98B
Treasury Stock	-18.73B	-9.77B	-17.5B	-26.58B	-31.14B
Comprehensive Income and Other	-2.79B	-1.96B	-3.1B	-6.25B	-6.42B
Total Common Equity	73.03B	92.53B	97.69B	91.39B	90.29B
Minority Interest	1.15B	1.37B	1.16B	1.09B	944M
Total Equity	82.7B	103B	107B	101B	99.98B
Total Liabilities And Equity	895B	1,116B	1,188B	1,180B	1,194B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.6B	1.81B	1.78B	1.68B	1.64B
ECS Total Common Shares Outstanding	1.59B	1.81B	1.77B	1.68B	1.63B
Book Value / Share	45.82	51.13	55.12	54.55	55.5
Tangible Book Value	63.78B	75.92B	72.5B	67.12B	66.53B
Tangible Book Value Per Share	40.01	41.95	40.91	40.06	40.89
Tangible Book Value Per Share (As Reported)	40.01	41.95	40.91	40.06	40.89
Total Debt	303B	342B	357B	367B	404B
Debt Equivalent of Unfunded Proj. Benefit Obligation	473M	349M	476M	491M	553M
Net Debt	-64.91B	-173B	-213B	-187B	-123B
Equity Method Investments, Total	2.36B	2.41B	2.21B	1.93B	1.92B
Full Time Employees	60.43K	68K	75K	82K	80K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	9.04B	11B	15.03B	11.03B	9.09B
Depreciation, Depletion & Amortization	2.33B	3.4B	3.6B	3.39B	3.66B
Amortization of Goodwill and Intangible Assets - (CF)	314M	373M	612M	610M	601M
Total Depreciation, Depletion & Amortization	2.64B	3.77B	4.22B	4B	4.26B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Total Asset Writedown	-	-	-	-	-
Provision for Credit Losses	162M	762M	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	1.15B	1.31B	2.08B	1.88B	1.71B
Provision and Write-off of Bad Debts	-	-	4M	280M	532M
Change in Trading Asset Securities	-13.67B	15.55B	9.08B	-39.42B	-61.03B
Change in Accounts Receivable	233M	-29.77B	774M	14.66B	602M
Change in Accounts Payable	19.94B	10.19B	7.76B	-4.9B	-3.63B
Change in Other Net Operating Assets (Collected)	21.1B	-38.24B	-4.92B	6.16B	14.94B
Other Operating Activities	165M	207M	-57M	-81M	-12M
Cash from Operations	40.77B	-25.23B	33.97B	-6.4B	-33.54B
Capital Expenditure	-1.83B	-1.44B	-2.31B	-3.08B	-3.41B
Cash Acquisitions	-	3.81B	-2.65B	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-13.42B	-21.51B	-8B	15.44B	5.31B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-17.36B	-17.95B	-36.11B	-23.65B	-4.06B
Other Investing Activities, Total	-953M	-802M	-832M	-347M	-923M
Cash from Investing	-33.56B	-37.9B	-49.9B	-11.63B	-3.08B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	34.3B	63.52B	90.27B	72.46B	79.22B
Total Debt Issued	34.3B	63.52B	90.27B	72.46B	79.22B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-40.55B	-50.48B	-70.75B	-35.78B	-64.8B
Total Debt Repaid	-40.55B	-50.48B	-70.75B	-35.78B	-64.8B
Repurchase of Common Stock	-5.95B	-1.89B	-12.08B	-10.87B	-6.18B
Issuance of Preferred Stock	497M	-	1.28B	994M	-
Common & Preferred Stock Dividends Paid	-2.63B	-2.74B	-4.17B	-5.4B	-5.76B
Common & Preferred Stock Dividends Paid	-2.63B	-2.74B	-4.17B	-5.4B	-5.76B
Other Financing Activities, Total	2.37B	75.38B	36.99B	1.31B	-5.2B
Cash from Financing	-11.97B	83.78B	41.55B	22.71B	-2.73B
Foreign Exchange Rate Adjustments	-271M	2.83B	-3.55B	-4.28B	451M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-5.02B	23.48B	22.07B	402M	-38.9B
Supplemental Items
Cash Interest Paid	12.51B	4.12B	1.3B	9.82B	41.94B
Cash Income Tax Paid (Refund)	1.91B	2.59B	4.23B	4.15B	2.04B
Net Debt Issued / Repaid	-6.25B	13.04B	19.52B	36.68B	14.42B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	1.06	1.11	1.31	0.94	0.78
Return On Equity %	11.26	12.03	14.42	10.76	9.17
Return on Common Equity	11.76	12.68	15.31	11.15	9.39
Margin Analysis
Gross Profit Margin %	88.68	88.81	89.19	86.98	86.47
SG&A Margin	55.26	51.66	49.92	53.79	56.06
Income From Continuing Operations Margin %	22.3	23.19	25.3	20.94	17.22
Net Income Margin %	21.83	22.81	25.16	20.66	16.95
Net Avail. For Common Margin %	20.55	21.79	24.38	19.74	15.91
Normalized Net Income Margin	17.21	19.04	20.75	16.8	14.26
Asset Turnover
Asset Turnover	0.05	0.05	0.05	0.05	0.05
Short Term Liquidity
Current Ratio	1.7	1.78	1.93	1.93	1.95
Quick Ratio	1.21	1.49	1.69	1.65	1.6
Operating Cash Flow to Current Liabilities	0.09	-0.05	0.07	-0.01	-0.07
Long Term Solvency
Total Debt/Equity	366.69	331.1	335.26	363	403.8
Total Debt / Total Capital	78.57	76.8	77.03	78.4	80.15
LT Debt/Equity	216.93	191.07	206.94	217.78	246.32
Long-Term Debt / Total Capital	46.48	44.32	47.54	47.04	48.89
Total Liabilities / Total Assets	90.76	90.76	91.03	91.42	91.62
Tier 1 Capital Ratio %	18.6	19.4	17.7	17.2	17.1
Total Capital Ratio %	21	21.5	19.7	19.3	19.5
Leverage Ratio %	8.3	8.4	7.1	6.7	6.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.27	16.37	24.49	-10.65	0.42
Gross Profit, 1 Yr. Growth %	2.9	16.53	25.09	-12.86	-0.17
Earnings From Cont. Operations, 1 Yr. Growth %	3.94	21.02	35.25	-26.06	-17.43
Net Income, 1 Yr. Growth %	3.36	21.61	36.72	-26.64	-17.61
Normalized Net Income, 1 Yr. Growth %	1.16	28.75	35.13	-27.67	-11.8
Diluted EPS Before Extra, 1 Yr. Growth %	9.73	24.47	24.3	-23.41	-15.77
Common Equity, 1 Yr. Growth %	1.82	26.7	5.58	-6.45	-1.21
Total Assets, 1 Yr. Growth %	4.91	24.62	6.48	-0.67	1.14
Tangible Book Value, 1 Yr. Growth %	1.43	19.03	-4.5	-7.42	-0.89
Cash From Operations, 1 Yr. Growth %	458.15	-161.88	-234.64